Technology
Positive
PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Breaking news from global financial markets
il y a 3 semaines
Lire Plus
il y a 3 semaines
1,857
il y a 3 semaines
3,742
TrustStrategy Boosts Market Position with AI Investing Innovations for Smarter Portfolio Management
Technology
il y a 3 semaines
954
il y a 3 semaines
2,538
il y a 3 semaines
2,407
il y a 3 semaines
1,160
il y a 3 semaines
945
EarlyHealth Group übernimmt CYB3R, das am schnellsten wachsende Cybersicherheitsunternehmen am Golf
Technology
il y a 3 semaines
4,342
il y a 3 semaines
752
il y a 3 semaines
3,002
il y a 3 semaines
3,718
il y a 3 semaines
4,772
Dental Expert Dr. Margaret Nichols of Hattiesburg Explains Same-Day Crowns for HelloNation
Technology
il y a 3 semaines
573
Tendances Actuelles
1
IO DeFi Launches New Mobile App, Making BTC and XRP Hashrate Earnings Accessible...
40,059
il y a 1 jour
2
BPCE : Mise à disposition du troisième amendement au document d’enregistrement u...
19,818
il y a 1 jour
3
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit w...
17,116
il y a 1 jour
4
BTCC November 2025 Product Update: Exchange Introduces Futures Pro Copy Trading
12,127
il y a 1 jour
5
4Thought Technologies CEO and EY Entrepreneur of the Year Award Nominee Richie S...
25,304
il y a 1 jour